UCSF

ZINC00006787

Substance Information

In ZINC since Heavy atoms Benign functionality
October 5th, 2005 17 Yes

Other Names:

"Resveratrol, 98%"

(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol

(E)-5-(4-Hydroxystyryl)benzene-1,3-diol

(E)-5-(p-Hydroxystyryl)resorcinol

(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol

(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol

(E)-resveratrol

1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-

1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; 3,4',5-Trihydroxystilbene; 3,4',5-stilbenetriol; 3,5,4'-Trihydroxystilbene; C14H12O3; LS-2146; NSC 327430; PREVENTION 8 (RESVERATROL); Resveratrol; trans-resveratrol

1,3-benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-

3,4',5-Stilbenetriol

3,4',5-trihydroxy-stilbene

3,4',5-Trihydroxy-trans-stilbene

3,4',5-Trihydroxystilbene

3,4',5-trihydroxystilbene; 3,5,4'-trihydroxystilbene; 501-36-0; CPD-83; resveratrol

3,4',5-Trihydroxystilbene; 501-36-0; C03582; Resveratrol; trans-Resveratrol

3,4',5-Trihydroxystilbene;trans-3,4',5 - Trihydroxystilbene;trans-Resveratrol

3,4_,5-Trihydroxy-trans-stilbene

3,5,4'-Trihydroxy-trans-stilbene

3,5,4'-Trihydroxystilbene

31100-06-8

34092_FLUKA

34092_RIEDEL

5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol

5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol

5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol

5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol

5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol

5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol

501-36-0

501-36-0; Prestwick_619; Resveratrol

533C1DA0-4104-42B5-9D32-9265F40857E4

AC-727

AC1L9HIC

BB_NC-2570

BPBio1_000479

BRD-K25591257-001-01-2

BRD-K80738081-001-06-2

BRD-K80738081-001-09-6

BRD-K80738081-001-10-4

BRD-K80738081-001-23-7

BSPBio_000435

BSPBio_001114

BSPBio_003461

C03582

C059514

C14H12O3

CCRIS 8952

CHEBI:1366; CHEBI:19867; CHEBI:11685

CHEBI:27881

CHEBI:36000; CHEBI:45712

CHEBI:45713

CHEMBL165

CID445154

cis-resveratrol

CPD-83

CPD000058206

CPD000058206; Resveratrol; 501-36-0

CPD000058206; RESVERATROL; SAM001246888

CU-01000001503-3

DB02709

DCL000234

DNC001205

EU-0101111

FT-0082623

HMS1362H15

HMS1569F17

HMS1792H15

HMS1921N04

HMS1990H15

HMS2052I09

HSDB 7571

HYDROXYSTYRYLBENZENEDIO

I06-0437

IDI1_002152

InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1

InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+

KSC-10-164

KUC104385N

LMPK13090005

LS-2146

LUKBXSAWLPMMSZ-OWOJBTEDSA-

MFCD00133799

MLS000069735

MLS001055357

MLS001076538

MLS002207121

MLS002222231

MolPort-002-499-801

N/A

NCGC00017352-07

NCGC00017352-17

NCGC00024003-00

NCGC00024003-04

NCGC00024003-05

NCGC00024003-06

NCGC00024003-07

NCGC00024003-08

NCGC00024003-09

NCGC00024003-10

NCGC00024003-11

nchembio.140-comp2

nchembio.281-comp10

NSC 327430

NSC327430

OR-1053

Prestwick2_000508

Prestwick3_000508

Prestwick_619

PREVENTION 8 (RESVERATROL)

R 5010

R0071

R5010_SIGMA

Resveratrol [501-36-0]; (trans-3,5,4'-Stilbenetriol)

Resveratrol, 98%+

Resveratrol, 99%

Resveratrol, E-

resveratrol-3-sulfate

RESVERATROL; [501-36-0]

Resvida

Resvida; trans-resveratrol

RM-1812

RV

S1396_Selleck

SAM001246888

SDCCGMLS-0002998.P003

SGCUT00007

SMR000058206

SPECTRUM1502223

Spectrum5_000552

SRT 501

SRT-501

SRT501

STL

TL8003323

to_000079

trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene

trans-3,4&prime

trans-3,4',5-trihydroxystilbene

trans-resveratrol

trans-Resveratrol-d4

ZINC00006787

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.99 0.79 -8.46 3 3 0 61 228.247 2

Vendor Notes

Note Type Comments Provided By
MP 253 - 255 °C Fluorochem
MP 253-255o C Indofine
MP 253-255°C Indofine
MP 254° Matrix Scientific
Mp [°C] 261 - 263 Acros Organics
MP 263-265° Oakwood Chemical
UniProt Database Links 4CL1_ARATH; 4CL1_DICDI; 4CL1_ORYSJ; 4CL1_PETCR; 4CL1_SOLTU; 4CL1_SOYBN; 4CL1_TOBAC; 4CL2_ARATH; 4CL2_DICDI; 4CL2_ORYSJ; 4CL2_PETCR; 4CL2_SOLTU; 4CL2_SOYBN; 4CL2_TOBAC; 4CL3_ARATH; 4CL3_DICDI; 4CL3_ORYSJ; 4CL4_ARATH; 4CL4_ORYSJ; 4CL5_ORYSJ; 4CL_PINTA; 4CL_ ChEBI
Purity 50-97% APIChem
ALOGPS_SOLUBILITY 6.88e-02 g/l DrugBank-experimental
Purity 95+% Matrix Scientific
Purity >98% Fluorochem
Indications antidiabetic KeyOrganics Bioactives
Indications antidiabetic, obesity, cancer KeyOrganics Bioactives
Therapy antifungal, antibacterial SMDC Iconix
Indications antioxidant, antiviral KeyOrganics Bioactives
biological_use Bactericide IBScreen Bioactives
Target Cellular tumor antigen p53(P04637)&Apoptosis regulator BAX(Q07812)&Apoptotic protease-activating factor 1(O14727)&RAC-alpha serine/threonine-protein kinase(P31749)&Signal transducer and activator of transcription 1-alpha/beta(P42224)&Caspase-3(P42574)&NAD Herbal Ingredients Targets
Patent Database Links EP1574499; EP1669067; EP1676570; EP1726292; EP1762234; EP1779858; EP1825850; EP1837056; EP1844784; EP1852430; EP1872792; EP1897530; EP1911358; EP1925311; EP1932516; EP1932517; EP1952796; EP1982603; EP1982707; EP1992322; GB2362101; US2003199581; US20041163 ChEBI
biological_use Fungicide IBScreen Bioactives IBScreen Bioactives
H phrase H318: Causes serious eye damage Acros Organics
H phrase H318: Causes serious eye damage; H335: May cause respiratory irritation; H315: Causes skin irritation; H317: May cause an allergic skin reaction; H302: Harmful if swallowed Acros Organics
Warnings IRRITANT Matrix Scientific
Target Mediator of DNA damage checkpoint protein 1(Q14676)&Cellular tumor antigen p53(P04637)&Cyclin-dependent kinase inhibitor 1(P38936)&Cell division control protein 2 homolog(P06493)&Apoptosis regulator BAX(Q07812) Herbal Ingredients Targets
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : R5010 NIH Clinical Collection via PubChem
biological_use Neutriceutical with a positive influence on blood lipid profile IBScreen Bioactives
P phrase P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing Acros Organics
P phrase P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing; P310: Immediately call a POISON CENTER or doctor/physician; P280: Wear eye protection/face protection; P26 Acros Organics
R phrase R22: Harmful if swallowed. Acros Organics
R phrase R22: Harmful if swallowed.; R37/38: Irritating to respiratory system and skin.; R41: Risk of serious damage to eyes.; R43: May cause sensitisation by skin contact. Acros Organics
biological_use Resveratrol in red wines has been postulated to be associated with beneficial health effects IBScreen Bioactives
S phrase S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Acros Organics
S phrase S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39: Wear suitable protective clothing, gloves and eye/face protection. Acros Organics
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: R5010 NIH Clinical Collection via PubChem
Target Sirtuin Selleck Chemicals
mechanism Tyrosinase inhibitor IBScreen Bioactives
Patent Database Links US2003069277; US2008268097; WO2005037843; WO2006101761; WO2007098091 ChEBI
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
AHR-1-E Aryl Hydrocarbon Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 169 0.56 Binding ≤ 10μM
CAH1-4-E Carbonic Anhydrase I (cluster #4 Of 12), Eukaryotic Eukaryotes 2210 0.47 Binding ≤ 10μM
CAH12-2-E Carbonic Anhydrase XII (cluster #2 Of 9), Eukaryotic Eukaryotes 950 0.50 Binding ≤ 10μM
CAH13-7-E Carbonic Anhydrase XIII (cluster #7 Of 7), Eukaryotic Eukaryotes 4090 0.44 Binding ≤ 10μM
CAH14-4-E Carbonic Anhydrase XIV (cluster #4 Of 8), Eukaryotic Eukaryotes 830 0.50 Binding ≤ 10μM
CAH15-1-E Carbonic Anhydrase 15 (cluster #1 Of 6), Eukaryotic Eukaryotes 9360 0.41 Binding ≤ 10μM
CAH2-5-E Carbonic Anhydrase II (cluster #5 Of 15), Eukaryotic Eukaryotes 2770 0.46 Binding ≤ 10μM
CAH3-1-E Carbonic Anhydrase III (cluster #1 Of 6), Eukaryotic Eukaryotes 9090 0.42 Binding ≤ 10μM
CAH4-3-E Carbonic Anhydrase IV (cluster #3 Of 16), Eukaryotic Eukaryotes 4470 0.44 Binding ≤ 10μM
CAH5A-8-E Carbonic Anhydrase VA (cluster #8 Of 10), Eukaryotic Eukaryotes 4750 0.44 Binding ≤ 10μM
CAH5B-4-E Carbonic Anhydrase VB (cluster #4 Of 9), Eukaryotic Eukaryotes 4640 0.44 Binding ≤ 10μM
CAH6-2-E Carbonic Anhydrase VI (cluster #2 Of 8), Eukaryotic Eukaryotes 8070 0.42 Binding ≤ 10μM
CAH7-2-E Carbonic Anhydrase VII (cluster #2 Of 8), Eukaryotic Eukaryotes 4350 0.44 Binding ≤ 10μM
CAH9-3-E Carbonic Anhydrase IX (cluster #3 Of 11), Eukaryotic Eukaryotes 810 0.50 Binding ≤ 10μM
ESR1-5-E Estrogen Receptor Alpha (cluster #5 Of 5), Eukaryotic Eukaryotes 785 0.50 Binding ≤ 10μM
NQO2-4-E Quinone Reductase 2 (cluster #4 Of 4), Eukaryotic Eukaryotes 960 0.50 Binding ≤ 10μM
PGH1-2-E Cyclooxygenase-1 (cluster #2 Of 6), Eukaryotic Eukaryotes 830 0.50 Binding ≤ 10μM
PGH2-1-E Cyclooxygenase-2 (cluster #1 Of 8), Eukaryotic Eukaryotes 3490 0.45 Binding ≤ 10μM
PGH1-1-E Cyclooxygenase-1 (cluster #1 Of 2), Eukaryotic Eukaryotes 2840 0.46 Functional ≤ 10μM
Z102306-4-O Aorta (cluster #4 Of 6), Other Other 6918 0.42 Functional ≤ 10μM
Z80156-1-O HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other Other 5000 0.44 Functional ≤ 10μM
Z80224-12-O MCF7 (Breast Carcinoma Cells) (cluster #12 Of 14), Other Other 0 0.00 Functional ≤ 10μM
Z80418-1-O RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #1 Of 9), Other Other 4000 0.44 Functional ≤ 10μM
Z80492-2-O SK-N-SH (Neuroblastoma Cells) (cluster #2 Of 2), Other Other 0 0.00 Functional ≤ 10μM
Z80682-7-O A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other Other 0 0.00 Functional ≤ 10μM
Z81247-2-O HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other Other 0 0.00 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
AHR_RABIT O02747 Aryl Hydrocarbon Receptor, Rabit 169 0.56 Binding ≤ 1μM
CAH9_HUMAN Q16790 Carbonic Anhydrase IX, Human 810 0.50 Binding ≤ 1μM
CAH12_HUMAN O43570 Carbonic Anhydrase XII, Human 950 0.50 Binding ≤ 1μM
CAH14_HUMAN Q9ULX7 Carbonic Anhydrase XIV, Human 830 0.50 Binding ≤ 1μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 830 0.50 Binding ≤ 1μM
PGH1_SHEEP P05979 Cyclooxygenase-1, Sheep 380 0.53 Binding ≤ 1μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 750 0.50 Binding ≤ 1μM
ESR1_HUMAN P03372 Estrogen Receptor Alpha, Human 785 0.50 Binding ≤ 1μM
NQO2_HUMAN P16083 Quinone Reductase 2, Human 450 0.52 Binding ≤ 1μM
AHR_RABIT O02747 Aryl Hydrocarbon Receptor, Rabit 169 0.56 Binding ≤ 10μM
CAH15_MOUSE Q99N23 Carbonic Anhydrase 15, Mouse 9360 0.41 Binding ≤ 10μM
CAH1_HUMAN P00915 Carbonic Anhydrase I, Human 2210 0.47 Binding ≤ 10μM
CAH2_HUMAN P00918 Carbonic Anhydrase II, Human 2770 0.46 Binding ≤ 10μM
CAH3_HUMAN P07451 Carbonic Anhydrase III, Human 9090 0.42 Binding ≤ 10μM
CAH4_HUMAN P22748 Carbonic Anhydrase IV, Human 4470 0.44 Binding ≤ 10μM
CAH9_HUMAN Q16790 Carbonic Anhydrase IX, Human 810 0.50 Binding ≤ 10μM
CAH5A_HUMAN P35218 Carbonic Anhydrase VA, Human 4750 0.44 Binding ≤ 10μM
CAH5B_HUMAN Q9Y2D0 Carbonic Anhydrase VB, Human 4640 0.44 Binding ≤ 10μM
CAH6_HUMAN P23280 Carbonic Anhydrase VI, Human 8070 0.42 Binding ≤ 10μM
CAH7_HUMAN P43166 Carbonic Anhydrase VII, Human 4350 0.44 Binding ≤ 10μM
CAH12_HUMAN O43570 Carbonic Anhydrase XII, Human 950 0.50 Binding ≤ 10μM
CAH13_HUMAN Q8N1Q1 Carbonic Anhydrase XIII, Human 4090 0.44 Binding ≤ 10μM
CAH14_HUMAN Q9ULX7 Carbonic Anhydrase XIV, Human 830 0.50 Binding ≤ 10μM
PGH1_SHEEP P05979 Cyclooxygenase-1, Sheep 2800 0.46 Binding ≤ 10μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 1100 0.49 Binding ≤ 10μM
PGH2_SHEEP P79208 Cyclooxygenase-2, Sheep 3490 0.45 Binding ≤ 10μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 1300 0.48 Binding ≤ 10μM
ESR1_HUMAN P03372 Estrogen Receptor Alpha, Human 785 0.50 Binding ≤ 10μM
NQO2_HUMAN P16083 Quinone Reductase 2, Human 450 0.52 Binding ≤ 10μM
Z80682 Z80682 A549 (Lung Carcinoma Cells) 0.1 0.82 Functional ≤ 10μM
Z102306 Z102306 Aorta 6918.30971 0.42 Functional ≤ 10μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 2840 0.46 Functional ≤ 10μM
Z81247 Z81247 HeLa (Cervical Adenocarcinoma Cells) 0.1 0.82 Functional ≤ 10μM
Z80156 Z80156 HL-60 (Promyeloblast Leukemia Cells) 5000 0.44 Functional ≤ 10μM
Z80224 Z80224 MCF7 (Breast Carcinoma Cells) 0.1 0.82 Functional ≤ 10μM
Z80418 Z80418 RAW264.7 (Monocytic-macrophage Leukemia Cells) 4000 0.44 Functional ≤ 10μM
Z80492 Z80492 SK-N-SH (Neuroblastoma Cells) 0.1 0.82 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
COX reactions
Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Nicotinamide salvaging
Nuclear Receptor transcription pathway
Nuclear signaling by ERBB4
Regulation of gene expression by Hypoxia-inducible Factor
Reversible hydration of carbon dioxide
Synthesis of 15-eicosatetraenoic acid derivatives
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)

Analogs ( Draw Identity 99% 90% 80% 70% )